Digital health firm Lyra enters unicorn territory after fundraisingDigital health startup Lyra Health has raised $110 million in fourth-round financing, raising its value above the $1 Share XDigital health firm Lyra enters unicorn territory after fundraisinghttps://pharmaphorum.com/news/digital-health-firm-lyra-enters-unicorn-territory-after-fundraising/
UK cancer mutation testing firm Biofidelity raises $12mCambridge, UK-based Biofidelity has raised $12 million in first-round funding for its cancer diagnosis platform, which can detect Share XUK cancer mutation testing firm Biofidelity raises $12mhttps://pharmaphorum.com/news/uk-cancer-mutation-testing-firm-biofidelity-raises-12m/
Novo-backed $61m fundraising helps F2G prep for antifungal launchAnglo-Austrian biotech F2G has raised $60.8 million in venture financing to help it bring a drug for life-threatening Share XNovo-backed $61m fundraising helps F2G prep for antifungal launchhttps://pharmaphorum.com/news/novo-backed-61m-fundraising-helps-f2g-prep-for-antifungal-launch/
UK biotech OMass raises £27.5m for GPCR drug discoveryOxford, UK-based OMass Therapeutics has extended its first-round financing to more than £41 million ($53 million), to help Share XUK biotech OMass raises £27.5m for GPCR drug discoveryhttps://pharmaphorum.com/news/uk-biotech-omass-raises-27-5m-for-gpcr-drug-discovery/
China’s Adagene raises $69m for cancer immunotherapiesChinese biotech Adagene has raised $69 million in fourth-round financing to help usher its immuno-oncology drugs – including Share XChina’s Adagene raises $69m for cancer immunotherapieshttps://pharmaphorum.com/news/chinas-adagene-raises-69m-for-cancer-immunotherapies/
France’s Doctolib is new digital health unicornDoctolib, the largest digital health service in Europe, has raised 150 million euros in a funding round, valuing Share XFrance’s Doctolib is new digital health unicornhttps://pharmaphorum.com/news/frances-doctolib-is-new-digital-health-unicorn/
Grey Wolf raises £10m for tumour ‘illumination’ techImmuno-oncology biotech Grey Wolf Therapeutics has raised £10 million in series A financing to develop therapies that increase Share XGrey Wolf raises £10m for tumour ‘illumination’ techhttps://pharmaphorum.com/news/grey-wolf-raises-10m-for-tumour-illumination-tech/
UK biotech riding on crest of VC funding wave – reportVenture capital funding for the UK biotech sector is robust following a solid start to the year, according Share XUK biotech riding on crest of VC funding wave – reporthttps://pharmaphorum.com/news/uk-biotech-riding-on-crest-of-vc-funding-wave-report/
PEAR raises $50m to develop digital therapeutics businessPEAR Therapeutics has raised $50m in a new financing round to fund development of its prescription digital therapeutics Share XPEAR raises $50m to develop digital therapeutics businesshttps://pharmaphorum.com/news/pear-raises-50m-develop-digital-therapeutics-business/
